Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs)

Nuclear retinoic acid receptors (RARs) are transcriptional regulators controlling the expression of specific subsets of genes in a ligand-dependent manner. The basic mechanism for switching on transcription of cognate target genes involves RAR binding at specific response elements and a network of interactions with coregulatory protein complexes, the assembly of which is directed by the C-terminal ligand-binding domain of RARs. In addition to this scenario, new roles for the N-terminal domain and the ubiquitin-proteasome system recently emerged. Moreover, the functions of RARs are not limited to the regulation of cognate target genes, as they can transrepress other gene pathways. Finally, RARs are also involved in nongenomic biological activities such as the activation of translation and of kinase cascades. Here we will review these mechanisms, focusing on how kinase signaling and the proteasome pathway cooperate to influence the dynamics of RAR transcriptional activity.

[1]  H. Gronemeyer,et al.  Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists. , 2009, Chemistry & biology.

[2]  I. Raška,et al.  SUG-1 Plays Proteolytic and Non-proteolytic Roles in the Control of Retinoic Acid Target Genes via Its Interaction with SRC-3* , 2009, Journal of Biological Chemistry.

[3]  I. Raška,et al.  Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. , 2009, Cancer research.

[4]  C. Ferry,et al.  A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARα to target promoters , 2009, The EMBO journal.

[5]  Lu Chen,et al.  Retinoic acid-gated sequence-specific translational control by RARα , 2008, Proceedings of the National Academy of Sciences.

[6]  Lu Chen,et al.  Synaptic Signaling by All-Trans Retinoic Acid in Homeostatic Synaptic Plasticity , 2008, Neuron.

[7]  Lu Chen,et al.  Retinoic acid regulates RARα-mediated control of translation in dendritic RNA granules during homeostatic synaptic plasticity , 2008, Proceedings of the National Academy of Sciences.

[8]  Danny Reinberg,et al.  Is there a code embedded in proteins that is based on post-translational modifications? , 2008, Nature Reviews Molecular Cell Biology.

[9]  Li-Na Wei,et al.  Modulation of retinoic acid receptor alpha activity by lysine methylation in the DNA binding domain. , 2008, Journal of proteome research.

[10]  Pawan Gupta,et al.  Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression , 2008, Proceedings of the National Academy of Sciences.

[11]  M. Cammarota,et al.  Retinoic acid induces apoptosis by a non-classical mechanism of ERK1/2 activation. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  J. L. Napoli,et al.  The Nuclear Transcription Factor RARα Associates with Neuronal RNA Granules and Suppresses Translation* , 2008, Journal of Biological Chemistry.

[13]  T. Schug,et al.  Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR , 2008, Proceedings of the National Academy of Sciences.

[14]  C. Glass,et al.  TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. , 2008, Molecular cell.

[15]  B. O’Malley,et al.  Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1. , 2008, Molecular cell.

[16]  F. Wang,et al.  Acinus-S′ Represses Retinoic Acid Receptor (RAR)-Regulated Gene Expression through Interaction with the B Domains of RARs , 2008, Molecular and Cellular Biology.

[17]  W. Miller,et al.  Topoisomerase II (cid:2) Negatively Modulates Retinoic Acid Receptor (cid:3) Function: a Novel Mechanism of Retinoic Acid Resistance (cid:1) , 2022 .

[18]  H. Stunnenberg,et al.  A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. , 2008, Molecular cell.

[19]  J. L. Napoli,et al.  All‐trans‐retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane‐associated RARα , 2008 .

[20]  J. L. Napoli,et al.  All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARalpha. , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Jessica Zucman-Rossi,et al.  Loss of Trim24 (Tif1α) gene function confers oncogenic activity to retinoic acid receptor alpha , 2007, Nature Genetics.

[22]  L. Gudas,et al.  Retinoic Acid Receptor Isotype Specificity in F9 Teratocarcinoma Stem Cells Results from the Differential Recruitment of Coregulators to Retinoic Acid Response Elements* , 2007, Journal of Biological Chemistry.

[23]  L. Altucci,et al.  RAR and RXR modulation in cancer and metabolic disease , 2007, Nature Reviews Drug Discovery.

[24]  Lucia Altucci,et al.  Design of selective nuclear receptor modulators: RAR and RXR as a case study , 2007, Nature Reviews Drug Discovery.

[25]  A. D. de Lera,et al.  Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. , 2007, Molecular endocrinology.

[26]  J. De-Castro Arce,et al.  Retinoic Acid Receptor β Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region* , 2007, Journal of Biological Chemistry.

[27]  L. Gudas,et al.  Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. , 2007, Journal of molecular biology.

[28]  B. O’Malley,et al.  SRC-3 Coactivator Functional Lifetime Is Regulated by a Phospho-Dependent Ubiquitin Time Clock , 2007, Cell.

[29]  C. Chomienne,et al.  Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells , 2007, Oncogene.

[30]  S. Lalevée,et al.  Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors. , 2007, Trends in cell biology.

[31]  F. Sladek,et al.  Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization. , 2007, Molecular endocrinology.

[32]  S. Collins,et al.  CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells. , 2007, The Journal of clinical investigation.

[33]  S. Khan,et al.  Lysine Trimethylation of Retinoic Acid Receptor-α , 2007, Molecular & Cellular Proteomics.

[34]  Mu Wang,et al.  CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR-c-SRC Signaling Axis Is Required for Neuritogenic Differentiation , 2007, Molecular and Cellular Biology.

[35]  L. Gudas,et al.  Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements. , 2007, The Journal of biological chemistry.

[36]  R. Nasr,et al.  Acute promyelocytic leukemia: new issues on pathogenesis and treatment response. , 2007, The international journal of biochemistry & cell biology.

[37]  S. Khan,et al.  Lysine trimethylation of retinoic acid receptor-alpha: a novel means to regulate receptor function. , 2007, Molecular & cellular proteomics : MCP.

[38]  G. Eichele,et al.  International Union of Pharmacology. LX. Retinoic Acid Receptors , 2006, Pharmacological Reviews.

[39]  Gregor Eichele,et al.  International Union of Pharmacology. LXIII. Retinoid X Receptors , 2006, Pharmacological Reviews.

[40]  Vincent Laudet,et al.  Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.

[41]  M. Beato,et al.  Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. , 2006, Molecular cell.

[42]  B. Haendler,et al.  Post-translational modifications of steroid receptors. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  V. Cavaillès,et al.  The nuclear receptor transcriptional coregulator RIP140 , 2006, Nuclear receptor signaling.

[44]  Hans Elmlund,et al.  The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II , 2006, Proceedings of the National Academy of Sciences.

[45]  B. Lefebvre,et al.  Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway. , 2006, Molecular endocrinology.

[46]  Masaru Mitsushima,et al.  Abl kinase interacts with and phosphorylates vinexin , 2006, FEBS letters.

[47]  B. Lefebvre,et al.  Distinct Roles of the Steroid Receptor Coactivator 1 and of MED1 in Retinoid-induced Transcription and Cellular Differentiation* , 2006, Journal of Biological Chemistry.

[48]  D. Moras,et al.  Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Christopher J. Oldfield,et al.  Intrinsic disorder in transcription factors. , 2006, Biochemistry.

[50]  C. Glass,et al.  Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. , 2006, Genes & development.

[51]  S. Dedieu,et al.  Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. , 2006, Cellular signalling.

[52]  P. Brown,et al.  Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. , 2006, The Biochemical journal.

[53]  P. Lijnzaad,et al.  Genome-wide location of the coactivator mediator: Binding without activation and transient Cdk8 interaction on DNA. , 2006, Molecular cell.

[54]  W. Tansey,et al.  The proteasome: a utility tool for transcription? , 2006, Current opinion in genetics & development.

[55]  J. Bastien,et al.  The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells , 2006, Oncogene.

[56]  T. Takenawa,et al.  Protein kinase A‐dependent increase in WAVE2 expression induced by the focal adhesion protein vinexin , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[57]  I. Raška,et al.  P38MAPK‐dependent phosphorylation and degradation of SRC‐3/AIB1 and RARα‐mediated transcription , 2006, The EMBO journal.

[58]  R. Taneja,et al.  Mouse embryocarcinoma F9 cells and retinoic acid: A model to study the molecular mechanisms of endodermal differentiation , 2006 .

[59]  J. Samama,et al.  Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Workman,et al.  The Proteasome Regulatory Particle Alters the SAGA Coactivator to Enhance Its Interactions with Transcriptional Activators , 2005, Cell.

[61]  A. Means,et al.  Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1) , 2005, Molecular and Cellular Biology.

[62]  I. McEwan,et al.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. , 2005, The Biochemical journal.

[63]  Pawan Gupta,et al.  Regulation of Co-repressive Activity of and HDAC Recruitment to RIP140 by Site-specific Phosphorylation * , 2005, Molecular & Cellular Proteomics.

[64]  C. Rochette-Egly Dynamic Combinatorial Networks in Nuclear Receptor-mediated Transcription* , 2005, Journal of Biological Chemistry.

[65]  R. Bernards,et al.  The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling , 2005, Cell.

[66]  V. Vivat-Hannah,et al.  Retinoids as therapeutic agents: today and tomorrow. , 2005, Mini reviews in medicinal chemistry.

[67]  Pierre Chambon,et al.  The nuclear receptor superfamily: a personal retrospect on the first two decades. , 2005, Molecular endocrinology.

[68]  Ronald Kühne,et al.  Recognition of proline-rich motifs by protein-protein-interaction domains. , 2005, Angewandte Chemie.

[69]  Jing-kun Pan,et al.  Activation of Rac1 by phosphatidylinositol 3‐kinase in vivo: role in activation of mitogen‐activated protein kinase (MAPK) pathways and retinoic acid‐induced neuronal differentiation of SH‐SY5Y cells , 2005, Journal of neurochemistry.

[70]  S. Khan,et al.  Mapping of phosphorylation sites of nuclear corepressor receptor interacting protein 140 by liquid chromatography‐tandem mass spectroscopy , 2005, Proteomics.

[71]  B. O’Malley,et al.  Transcriptional regulation by steroid receptor coactivator phosphorylation. , 2005, Endocrine reviews.

[72]  K. Lu,et al.  Phosphorylation-specific prolyl isomerization: is there an underlying theme? , 2005, Nature Cell Biology.

[73]  D. Reinberg,et al.  PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. , 2005, Molecular cell.

[74]  T. Klimkait,et al.  The peptidyl–prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor α stability , 2005 .

[75]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[76]  S. Lalevée,et al.  Vinexin β Interacts with the Non-phosphorylated AF-1 Domain of Retinoid Receptor γ (RARγ) and Represses RARγ-mediated Transcription* , 2005, Journal of Biological Chemistry.

[77]  R. Price,et al.  c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor α , 2005, Molecular and Cellular Biology.

[78]  B. O’Malley,et al.  Rush hour at the promoter: How the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[79]  H. Gronemeyer,et al.  Characterization of the Interaction between Retinoic Acid Receptor/Retinoid X Receptor (RAR/RXR) Heterodimers and Transcriptional Coactivators through Structural and Fluorescence Anisotropy Studies* , 2005, Journal of Biological Chemistry.

[80]  S. Dedieu,et al.  Transcriptional activities of retinoic acid receptors. , 2005, Vitamins and hormones.

[81]  M. Karamouzis,et al.  Retinoid receptor cross-talk in respiratory epithelium cancer chemoprevention. , 2005, Trends in molecular medicine.

[82]  M. Privalsky,et al.  SMRT and N-CoR Corepressors Are Regulated by Distinct Kinase Signaling Pathways* , 2004, Journal of Biological Chemistry.

[83]  W. Miller,et al.  Retinoic acid mediates degradation of IRS-1 by the ubiquitin–proteasome pathway, via a PKC-dependant mechanism , 2004, Oncogene.

[84]  H. Gronemeyer,et al.  Monitoring ligand-mediated nuclear receptor-coregulator interactions by noncovalent mass spectrometry. , 2004, European journal of biochemistry.

[85]  B. Farboud,et al.  Retinoic acid receptor-alpha is stabilized in a repressive state by its C-terminal, isotype-specific F domain. , 2004, Molecular endocrinology.

[86]  J. Qin,et al.  Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. , 2004, Molecular cell.

[87]  J. Starrett,et al.  Rational design of RAR‐selective ligands revealed by RARβ crystal stucture , 2004, EMBO reports.

[88]  H. Hausen,et al.  Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[89]  R. Aebersold,et al.  A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A , 2004, Nature Genetics.

[90]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[91]  Olivier Poch,et al.  Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level , 2004, EMBO reports.

[92]  J. Bastien,et al.  Nuclear retinoid receptors and the transcription of retinoid-target genes. , 2004, Gene.

[93]  Robert E. Cohen,et al.  Proteasomes and their kin: proteases in the machine age , 2004, Nature Reviews Molecular Cell Biology.

[94]  C. Glass,et al.  A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.

[95]  E. Ezhkova,et al.  Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. , 2004, Molecular cell.

[96]  M. Privalsky,et al.  The role of corepressors in transcriptional regulation by nuclear hormone receptors. , 2004, Annual review of physiology.

[97]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[98]  C. Chiang,et al.  Suppressive Effect of Receptor-interacting Protein 140 on Coregulator Binding to Retinoic Acid Receptor Complexes, Histone-modifying Enzyme Activity, and Gene Activation* , 2004, Journal of Biological Chemistry.

[99]  J. Gustafsson,et al.  Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. , 2003, Molecular endocrinology.

[100]  R. Deshaies,et al.  Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation , 2003, Nature Cell Biology.

[101]  D. Moras,et al.  Structure-activity relationship of nuclear receptor-ligand interactions. , 2003, Current topics in medicinal chemistry.

[102]  M. Lambert,et al.  Activation of nuclear receptors: a perspective from structural genomics. , 2003, Structure.

[103]  S. Minucci,et al.  Activation of Protein Kinase Cδ by All-trans-retinoic Acid* , 2003, Journal of Biological Chemistry.

[104]  Adrian V. Lee,et al.  SAFB2, a New Scaffold Attachment Factor Homolog and Estrogen Receptor Corepressor* , 2003, Journal of Biological Chemistry.

[105]  B. Farboud,et al.  Isotype-Restricted Corepressor Recruitment: a Constitutively Closed Helix 12 Conformation in Retinoic Acid Receptors β and γ Interferes with Corepressor Recruitment and Prevents Transcriptional Repression , 2003, Molecular and Cellular Biology.

[106]  B. Farboud,et al.  Retinoic Acid Receptors β and γ Do Not Repress, But Instead Activate Target Gene Transcription in Both the Absence and Presence of Hormone Ligand , 2003 .

[107]  M. Muratani,et al.  How the ubiquitin–proteasome system controls transcription , 2003, Nature Reviews Molecular Cell Biology.

[108]  C. Chomienne,et al.  Cyclin D3 Is a Cofactor of Retinoic Acid Receptors, Modulating Their Activity in the Presence of Cellular Retinoic Acid-binding Protein II* , 2003, The Journal of Biological Chemistry.

[109]  L. Banaszak,et al.  Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity. , 2003, Biochemistry.

[110]  Lucia Altucci,et al.  Nuclear receptor superfamily: Principles of signaling , 2003 .

[111]  Alfonso Bellacosa,et al.  The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. , 2003, Molecular cancer research : MCR.

[112]  P. Tompa Intrinsically unstructured proteins. , 2002, Trends in biochemical sciences.

[113]  M. Hung,et al.  Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells , 2002, Oncogene.

[114]  P. Chambon,et al.  Phosphorylation by p38MAPK and recruitment of SUG‐1 are required for RA‐induced RARγ degradation and transactivation , 2002, The EMBO journal.

[115]  P. Chambon,et al.  Down-regulation of the Phosphatidylinositol 3-Kinase/Akt Pathway Is Involved in Retinoic Acid-induced Phosphorylation, Degradation, and Transcriptional Activity of Retinoic Acid Receptor γ2* , 2002, The Journal of Biological Chemistry.

[116]  P. Lefebvre,et al.  Retinoic Acid Receptors Inhibit AP1 Activation by Regulating Extracellular Signal-Regulated Kinase and CBP Recruitment to an AP1-Responsive Promoter , 2002, Molecular and Cellular Biology.

[117]  N. McKenna,et al.  Minireview: Nuclear Receptor Coactivators-An Update. , 2002, Endocrinology.

[118]  A. Budhu,et al.  Direct Channeling of Retinoic Acid between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest , 2002, Molecular and Cellular Biology.

[119]  A. Sarasin,et al.  XPD Mutations Prevent TFIIH-Dependent Transactivation by Nuclear Receptors and Phosphorylation of RARα , 2002, Cell.

[120]  N. Colburn,et al.  AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers , 2002, Oncogene.

[121]  R. Kingston,et al.  Cooperation between Complexes that Regulate Chromatin Structure and Transcription , 2002, Cell.

[122]  S. Elgin,et al.  Epigenetic Codes for Heterochromatin Formation and Silencing Rounding up the Usual Suspects , 2002, Cell.

[123]  Marius Sudol,et al.  WW and SH3 domains, two different scaffolds to recognize proline‐rich ligands , 2002, FEBS letters.

[124]  T. Amachi,et al.  Vinexin, CAP/ponsin, ArgBP2: a novel adaptor protein family regulating cytoskeletal organization and signal transduction. , 2002, Cell structure and function.

[125]  Ralph A. Bradshaw,et al.  Post‐Translational Modifications , 2002 .

[126]  H. Gronemeyer,et al.  Co-regulator recruitment and the mechanism of retinoic acid receptor synergy , 2002, Nature.

[127]  N. McKenna,et al.  0013-7227/02/$15.00/0 Endocrinology 143(7):2461–2465 Printed in U.S.A. Copyright © 2002 by The Endocrine Society Minireview: Nuclear Receptor Coactivators—An Update , 2022 .

[128]  Lucia Altucci,et al.  Nuclear receptors in cell life and death , 2001, Trends in Endocrinology & Metabolism.

[129]  G. Orphanides,et al.  Estrogen receptors: orchestrators of pleiotropic cellular responses , 2001, EMBO reports.

[130]  Á. Pascual,et al.  Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.

[131]  C. Turck,et al.  Growth Factors Signal to Steroid Receptors through Mitogen-activated Protein Kinase Regulation of p160 Coactivator Activity* , 2001, The Journal of Biological Chemistry.

[132]  S. Khorasanizadeh,et al.  Nuclear-receptor interactions on DNA-response elements. , 2001, Trends in biochemical sciences.

[133]  A. Steinmetz,et al.  Binding of ligands and activation of transcription by nuclear receptors. , 2001, Annual review of biophysics and biomolecular structure.

[134]  F. Dilworth,et al.  Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription , 2001, Oncogene.

[135]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[136]  W. Tansey,et al.  Transcriptional activation: risky business. , 2001, Genes & development.

[137]  R. Goodman,et al.  CREB-binding Protein and p300 in Transcriptional Regulation* , 2001, The Journal of Biological Chemistry.

[138]  D. Moras,et al.  Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. , 2001, Journal of molecular biology.

[139]  Krzysztof Sliwa,et al.  Functions of WW domains in the nucleus , 2001, FEBS letters.

[140]  S. Minucci,et al.  Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to All-trans-retinoic Acid* , 2001, The Journal of Biological Chemistry.

[141]  F. Rastinejad Retinoid X receptor and its partners in the nuclear receptor family. , 2001, Current opinion in structural biology.

[142]  Xinli Hu,et al.  Receptor-interacting Protein 140 Directly Recruits Histone Deacetylases for Gene Silencing* , 2000, The Journal of Biological Chemistry.

[143]  D. Moras,et al.  Structural studies on nuclear receptors , 2000, Cellular and Molecular Life Sciences CMLS.

[144]  P. Chambon,et al.  Dimerization with Retinoid X Receptors and Phosphorylation Modulate the Retinoic Acid-induced Degradation of Retinoic Acid Receptors α and γ through the Ubiquitin-Proteasome Pathway* , 2000, The Journal of Biological Chemistry.

[145]  Y. Wan,et al.  Identification of Retinoic Acid-Responsive Elements on the HNF1α and HNF4α Genes , 2000 .

[146]  H. Gronemeyer,et al.  Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.

[147]  D. Moras,et al.  Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. , 2000, Journal of molecular biology.

[148]  M. Petkovich,et al.  Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. , 2000, Molecular endocrinology.

[149]  W. Lim,et al.  Converging on proline: the mechanism of WW domain peptide recognition , 2000, Nature Structural Biology.

[150]  P. Chambon,et al.  TFIIH Interacts with the Retinoic Acid Receptor γ and Phosphorylates Its AF-1-activating Domain through cdk7* , 2000, The Journal of Biological Chemistry.

[151]  F. Lin,et al.  Unique anti-activator protein-1 activity of retinoic acid receptor beta. , 2000, Cancer research.

[152]  S. Khorasanizadeh,et al.  Structure of the RXR–RAR DNA‐binding complex on the retinoic acid response element DR1 , 2000, The EMBO journal.

[153]  B. O’Malley,et al.  Phosphorylation of Steroid Receptor Coactivator-1 , 2000, The Journal of Biological Chemistry.

[154]  P. Chambon,et al.  Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. , 2000, Molecular cell.

[155]  M. Sudol,et al.  The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[156]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[157]  T. Magee,et al.  Identification of retinoic acid-responsive elements on the HNF1alpha and HNF4alpha genes. , 2000, Biochemical and biophysical research communications.

[158]  P. Lefebvre,et al.  Serine 157, a Retinoic Acid Receptor α Residue Phosphorylated by Protein Kinase C in Vitro, Is Involved in RXR·RARα Heterodimerization and Transcriptional Activity* , 1999, The Journal of Biological Chemistry.

[159]  M. Koken,et al.  Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor α (RARα) and Oncogenic RARα Fusion Proteins , 1999 .

[160]  C. Glass,et al.  Molecular determinants of nuclear receptor-corepressor interaction. , 1999, Genes & development.

[161]  M. Lazar,et al.  The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors , 1999, Nature.

[162]  P. Chambon,et al.  Physical and Functional Interactions between Cellular Retinoic Acid Binding Protein II and the Retinoic Acid-Dependent Nuclear Complex , 1999, Molecular and Cellular Biology.

[163]  D. Levinthal,et al.  Distinct Roles for Cellular Retinoic Acid-binding Proteins I and II in Regulating Signaling by Retinoic Acid* , 1999, The Journal of Biological Chemistry.

[164]  P Chambon,et al.  Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. , 1999, Chemistry & biology.

[165]  M. Koken,et al.  Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[166]  H. Gronemeyer,et al.  The nuclear receptor ligand-binding domain: structure and function. , 1998, Current opinion in cell biology.

[167]  P. Chambon,et al.  Conformational adaptation of agonists to the human nuclear receptor RARγ , 1998, Nature Structural Biology.

[168]  H. Gronemeyer,et al.  Therapeutic potential of selective modulators of nuclear receptor action. , 1998, Current opinion in chemical biology.

[169]  R. Ogawa [Down regulation]. , 1998, Masui. The Japanese journal of anesthesiology.

[170]  P. Chambon,et al.  Stimulation of RARα Activation Function AF-1 through Binding to the General Transcription Factor TFIIH and Phosphorylation by CDK7 , 1997, Cell.

[171]  David M. Heery,et al.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.

[172]  P. Chambon,et al.  In vivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE). , 1997, Development.

[173]  S. Nagpal,et al.  Identification and Functional Separation of Retinoic Acid Receptor Neutral Antagonists and Inverse Agonists* , 1996, The Journal of Biological Chemistry.

[174]  P. Chambon A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[175]  Z. Dong,et al.  Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. , 1996, Cancer research.

[176]  P. Chambon,et al.  Differential ligand‐dependent interactions between the AF‐2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. , 1996, The EMBO journal.

[177]  William Bourguet,et al.  A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.

[178]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[179]  Jean-Paul Renaud,et al.  Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.

[180]  P. Chambon,et al.  Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. , 1995, Molecular endocrinology.

[181]  William Bourguet,et al.  Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.

[182]  P. Chambon,et al.  The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.

[183]  P. Chambon,et al.  RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation. , 1995, The EMBO journal.

[184]  Hendrik G. Stunnenberg,et al.  Retinoic Acid Receptors , 1995 .

[185]  A. Fanjul,et al.  A new class of retinoids with selective inhibition of AP-1 inhibits proliferation , 1994, Nature.

[186]  P. Chambon,et al.  The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full‐length receptors to direct repeats. , 1994, The EMBO journal.

[187]  P. Chambon,et al.  Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. , 1994, The EMBO journal.

[188]  Z. Dong,et al.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[189]  P. Chambon,et al.  RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo. , 1993, The EMBO journal.

[190]  S. Kliewer,et al.  Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. , 1993, Science.

[191]  P. Brickell,et al.  The nuclear retinoid receptors. , 1993, International journal of experimental pathology.

[192]  P. Chambon,et al.  All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs , 1992, Cell.

[193]  P. Chambon,et al.  Multiplicity generates diversity in the retinoic acid signalling pathways. , 1992, Trends in biochemical sciences.

[194]  P. Chambon,et al.  Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors , 1992, Cell.

[195]  K. Umesono,et al.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR , 1991, Cell.

[196]  P. Chambon,et al.  A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. , 1991, The EMBO journal.

[197]  P. Chambon,et al.  Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. , 1990, The EMBO journal.

[198]  M. Sporn,et al.  Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5' activator protein-1-binding site. , 1990, Molecular endocrinology.

[199]  H. Stunnenberg,et al.  Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.

[200]  B. Sefton,et al.  Protein kinases. , 1989, Cancer cells.

[201]  L. Beevers Post-Translational Modifications , 1982 .